Related Experiment Video
Updated: Mar 7, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Transforming Cancer Epigenetics Using Nutritive Approaches and Noncoding RNAs
Centdrika R Dates1, Trygve O Tollefsbol1,2,3,4,5
1Department of Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States.
Abstract:
Cancer is considered one of the leading causes of death in the United States. Although preventive strategies, early detection, and improved treatment options have been developed, novel targets and therapeutics are still needed. Since concluding that cancer is mediated by genetic and epigenetic alterations of the cell, many research groups are now focusing on other means of prevention and therapy via nutrition, epigenetic mechanisms, and non-coding RNAs which have been shown to control gene expression and have many different functions at the cellular level. With the advent of high-throughput sequencing in human cancer, the potential to identify novel biomarkers and therapeutic targets of disease has increased tremendously and led to the identification of many non-coding RNAs that are dysregulated in various cancers. Gene expression and regulation is important in maintaining the homeostasis of normal tissues and cells. Not uncommonly, up- or down-regulation of particular genes are associated with cancer as a result of increased or decreased expression of transcriptional targets. This review focuses on the role of nutrition in cancer and the dysregulation of non-coding RNAs with particular emphasis on long non-coding RNAs and microRNAs in different cancer types.
Insights
Nutrition and non-coding RNAs (ncRNAs) are key areas for cancer prevention and therapy. This review explores how ncRNAs, like long non-coding RNAs and microRNAs, are dysregulated in cancer, impacting gene expression and offering novel therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer remains a leading cause of death, necessitating novel therapeutic and preventive strategies.
- Epigenetic alterations, including non-coding RNA dysregulation, are increasingly recognized as crucial in cancer development.
- Nutrition plays a significant role in cellular homeostasis and cancer etiology.
Purpose of the Study:
- To review the role of nutrition in cancer development and progression.
- To examine the dysregulation of non-coding RNAs (ncRNAs) in various cancer types.
- To highlight ncRNAs, particularly long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), as potential biomarkers and therapeutic targets.
Main Methods:
- Literature review focusing on cancer, nutrition, and non-coding RNA research.
- Analysis of studies investigating gene expression and regulation in cancer.
- Emphasis on high-throughput sequencing data for identifying dysregulated ncRNAs.
Main Results:
- Non-coding RNAs, including lncRNAs and miRNAs, are frequently dysregulated in cancer, affecting gene expression.
- Altered expression of specific ncRNAs correlates with cancer development and progression.
- Nutritional factors can influence epigenetic mechanisms and ncRNA expression.
Conclusions:
- Nutrition and ncRNA dysregulation are critical factors in cancer.
- ncRNAs represent promising biomarkers for early detection and novel therapeutic targets in oncology.
- Further research into the interplay between nutrition and ncRNAs can lead to innovative cancer prevention and treatment strategies.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cancer
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Prevention
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

